Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-ethyl-3-benzofuranyl-4-hydroxy-3,5-diiodophenyl Ketone
2. Algocor
3. Amplivix
4. Cardivix
5. Dila-vasal
6. Dilafurane
1. 68-90-6
2. Amplivix
3. Dilafurane
4. Cardivix
5. Dila-vasal
6. Corofam
7. Coronal-crinos
8. Retrangor
9. Benziodaron
10. Carofam
11. Dilacoron
12. L 2329
13. 2329 Labaz
14. Nsc 82133
15. 2-ethyl-3-benzofuranyl 4-hydroxy-3,5-diiodophenyl Ketone
16. Nsc-82133
17. 75cl65gtyr
18. 2-ethyl-3-(3',5'-diiodo-4'-hydroxybenzoyl)-cumarone
19. Benzofuran, 3-(3,5-diiodo-4-hydroxybenzoyl)-2-ethyl-
20. 3,5-diiodo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl Ketone
21. Chembl232201
22. Corofam;dilacoron;nsc 82133
23. (2-ethylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone
24. Methanone, (2-ethyl-3-benzofuranyl)(4-hydroxy-3,5-diiodophenyl)-
25. Aethyl-2-(3',5'-dijod-4'-oxybenzoyl)-3 Cumaron
26. Ncgc00160408-01
27. Plexocardio
28. Flanicone
29. Ketone, 2-ethyl-3-benzofuranyl 4-hydroxy-3,5-diiodophenyl
30. Ketone, 3,5-diiodo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl
31. Uricor
32. L-2329
33. Dsstox_cid_26134
34. Dsstox_rid_81367
35. Dsstox_gsid_46134
36. Benziodarona
37. Benziodaronum
38. Benzoiodarone
39. Benziodaronum [inn-latin]
40. Cas-68-90-6
41. Benziodarona [inn-spanish]
42. Einecs 200-695-2
43. Unii-75cl65gtyr
44. Brn 1257683
45. Amplivix (tn)
46. Benziodarone [inn:ban:dcf:jan]
47. Ketone,5-diiodophenyl
48. Aethyl-2-(3',5'-dijod-4'-oxybenzoyl)-3 Cumaron [german]
49. Benziodarone (jan/inn)
50. Benziodarone [mi]
51. Benziodarone [inn]
52. Benziodarone [jan]
53. Methanone,5-diiodophenyl)-
54. Benziodarone [mart.]
55. Benziodarone [who-dd]
56. Schembl308541
57. Dtxsid1046134
58. Chebi:135814
59. Nsc82133
60. Zinc3875456
61. Tox21_111793
62. (2-ethyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
63. Bdbm50209206
64. Mfcd00868246
65. Akos015994715
66. Tox21_111793_1
67. Db13277
68. Ks-1133
69. Ncgc00160408-02
70. Ncgc00160408-03
71. Ncgc00160408-06
72. E1290
73. Ft-0662545
74. D01833
75. T72830
76. Q4890775
77. 2-ethylbenzofuranyl 4-hydroxy-3,5-diiodophenyl Ketone
78. (2-ethyl-1-benzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone #
Molecular Weight | 518.08 g/mol |
---|---|
Molecular Formula | C17H12I2O3 |
XLogP3 | 5.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 517.88759 g/mol |
Monoisotopic Mass | 517.88759 g/mol |
Topological Polar Surface Area | 50.4 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 405 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Uricosuric Agents
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01D - Vasodilators used in cardiac diseases
C01DX - Other vasodilators used in cardiac diseases
C01DX04 - Benziodarone
Global Sales Information
ABOUT THIS PAGE
A Benziodarone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benziodarone, including repackagers and relabelers. The FDA regulates Benziodarone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benziodarone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benziodarone supplier is an individual or a company that provides Benziodarone active pharmaceutical ingredient (API) or Benziodarone finished formulations upon request. The Benziodarone suppliers may include Benziodarone API manufacturers, exporters, distributors and traders.
Benziodarone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benziodarone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benziodarone GMP manufacturer or Benziodarone GMP API supplier for your needs.
A Benziodarone CoA (Certificate of Analysis) is a formal document that attests to Benziodarone's compliance with Benziodarone specifications and serves as a tool for batch-level quality control.
Benziodarone CoA mostly includes findings from lab analyses of a specific batch. For each Benziodarone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benziodarone may be tested according to a variety of international standards, such as European Pharmacopoeia (Benziodarone EP), Benziodarone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benziodarone USP).
LOOKING FOR A SUPPLIER?